Industry / Iran
Drug Manufacture To Boost Local Pharmaceutical Market Spending
March 2010 | Industry Trend AnalysisIranian drugmaker Soha Pharmaceuticals has mass produced generic copies of venflaxine and the antibiotic clindamycin. Whether these are approved generic versions is unclear, but BMI notes that Iran is becoming increasingly self-sufficient in meeting local demand for medicines as a result of the ongoing US-led trade embargo.
To read the full article, please choose one of the following options:
Subcribers please log in




